Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study
奇格列他扎治疗伴有高甘油三酯血症和胰岛素抵抗的MASLD:一项II期随机、双盲、安慰剂对照研究
期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000001475
Sun, Yameng; Wu, Cuisong; Xin, Guijie; Zhong, Bihui; Wu, Xiaofeng; Liu, Yali; Shi, Junping; Zhang, Qin; Zhao, Yingren; Gao, Yufeng; Xin, Yongning; Zhu, Yueyong; Wu, Lixian; Mao, Xiaorong; Du, Jian; Shang, Jia; Sun, Weiwei; Xu, Jie; Yu, Zujiang; Nan, Yuemin; Sheng, Huiping; Li, Yue; Rao, Huiying; Yu, Chaohui; Cao, Haixiang; Chen, Bo; Li, Zhibin; Wu, Xiaoning; Tong, Xiaofei; You, Hong